dbGaP Protocol: The Pediatric Cardiac Genetics Consortium (PCGC)
NCT ID: NCT03347214
Last Updated: 2020-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
6260 participants
OBSERVATIONAL
2017-10-20
2020-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Researchers do not know much about the causes of congenital heart disease (CHD). They do know that many factors play a role. Some factors are environmental. Some are genetic. But few specific factors have been identified. And researchers do not know how many involve genes. They want to study data that has already been collected from people with CHD and their families.
Objectives:
To identify genetic variations related to CHD. To study molecules related to vascular disease in order to learn new ways to treat it.
Eligibility:
People who already participated in the Pediatric Cardiac Genomics Consortium (PCGC) study
Design:
Researchers will study data that was already collected in the PCGC. There will be no active participants.
Researchers will get access to the data through the coordinating center. They will not download data to local storage devices.
The data will have no personally identifying information....
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetics of Congenital Heart Disease
NCT01192048
An Evaluation of Routine Developmental Follow-Up in Infants and Children With Congenital Heart Disease
NCT01567579
Pediatric Cardiomyopathy Mutation Analysis
NCT02432092
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
NCT01873963
Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
NCT01196182
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
People who already participated in the Pediatric Cardiac Genomics Consortium (PCGC) study
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan R Kaltman, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Heart, Lung, and Blood Institute (NHLBI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-H-N006
Identifier Type: -
Identifier Source: secondary_id
999918006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.